143 related articles for article (PubMed ID: 31389293)
1. Association between prolactin receptor expression and proliferation in the endometrium of obese women with polycystic ovary syndrome.
Paulson M; Norstedt G; Sahlin L; Hirschberg AL
Gynecol Endocrinol; 2020 Mar; 36(3):226-232. PubMed ID: 31389293
[TBL] [Abstract][Full Text] [Related]
2. Progesterone Receptors and Proliferation of the Endometrium in Obese Women With Polycystic Ovary Syndrome-A Lifestyle Intervention Study.
Paulson M; Sahlin L; Hirschberg AL
J Clin Endocrinol Metab; 2017 Apr; 102(4):1244-1253. PubMed ID: 28388727
[TBL] [Abstract][Full Text] [Related]
3. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.
Ujvari D; Hulchiy M; Calaby A; Nybacka Å; Byström B; Hirschberg AL
Hum Reprod; 2014 Jul; 29(7):1526-35. PubMed ID: 24842895
[TBL] [Abstract][Full Text] [Related]
4. Endometrial Expression of Estrogen Receptors and the Androgen Receptor in Women With Polycystic Ovary Syndrome: A Lifestyle Intervention Study.
Hulchiy M; Nybacka Å; Sahlin L; Hirschberg AL
J Clin Endocrinol Metab; 2016 Feb; 101(2):561-71. PubMed ID: 26649621
[TBL] [Abstract][Full Text] [Related]
5. Women with polycystic ovary syndrome present with altered endometrial expression of stanniocalcin-1†.
Khatun M; Arffman RK; Lavogina D; Kangasniemi M; Laru J; Ahtikoski A; Lehtonen S; Paulson M; Hirschberg AL; Salumets A; Andersson LC; Piltonen TT
Biol Reprod; 2020 Feb; 102(2):306-315. PubMed ID: 31494675
[TBL] [Abstract][Full Text] [Related]
6. [Features of morphometry of ultrasound and endometrial histology in the anovulatory polycystic ovary syndrome women].
Zhang EH; Liang XY; DU J; Li SP; Hu RD; Xu YW; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):380-3. PubMed ID: 16831358
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem/progenitors and other endometrial cell types from women with polycystic ovary syndrome (PCOS) display inflammatory and oncogenic potential.
Piltonen TT; Chen J; Erikson DW; Spitzer TL; Barragan F; Rabban JT; Huddleston H; Irwin JC; Giudice LC
J Clin Endocrinol Metab; 2013 Sep; 98(9):3765-75. PubMed ID: 23824412
[TBL] [Abstract][Full Text] [Related]
8. [Expression of leptin and long form of leptin receptors messenger ribonucleic acid and protein in endometrium of patients with polycystic ovary syndrome].
Wang YZ; Qiao J; Liu LL; Chen YJ; Li MZ
Zhonghua Fu Chan Ke Za Zhi; 2003 Jul; 38(7):398-401. PubMed ID: 12921548
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of IL-18 in the Proliferative Phase Endometrium of Patients With Polycystic Ovary Syndrome.
Long X; Li R; Yang Y; Qiao J
Reprod Sci; 2017 Feb; 24(2):252-257. PubMed ID: 27313119
[TBL] [Abstract][Full Text] [Related]
10. Effects of metformin on the expression of GLUT4 in endometrium of obese women with polycystic ovary syndrome.
Zhai J; Liu CX; Tian ZR; Jiang QH; Sun YP
Biol Reprod; 2012 Aug; 87(2):29. PubMed ID: 22572996
[TBL] [Abstract][Full Text] [Related]
11. Effects of daily low dose mifepristone on endometrial maturation and proliferation.
Cameron ST; Critchley HO; Thong KJ; Buckley CH; Williams AR; Baird DT
Hum Reprod; 1996 Nov; 11(11):2518-26. PubMed ID: 8981147
[TBL] [Abstract][Full Text] [Related]
12. The prolactin receptor gene (PRLR) is linked and associated with the risk of polycystic ovarian syndrome.
Amin M; Gragnoli C
J Ovarian Res; 2023 Nov; 16(1):222. PubMed ID: 37993904
[TBL] [Abstract][Full Text] [Related]
13. Characterization of GAB1 expression over the menstrual cycle in women with and without polycystic ovarian syndrome provides a new insight into its pathophysiology.
Roemer KL; Young SL; Savaris RF
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2162-8. PubMed ID: 25144631
[TBL] [Abstract][Full Text] [Related]
14. Expression of molecules associated with tissue homeostasis in secretory endometria from untreated women with polycystic ovary syndrome.
Avellaira C; Villavicencio A; Bacallao K; Gabler F; Wells P; Romero C; Vega M
Hum Reprod; 2006 Dec; 21(12):3116-21. PubMed ID: 17008325
[TBL] [Abstract][Full Text] [Related]
15. Analysis of hyaluronic acid in the endometrium of women with polycystic ovary syndrome.
Santos Simões R; Carbonel AAF; Borges FT; Baracat MCP; da Silva Sasso GR; Simões MJ; Serafini PC; Soares JM; Nader HB; Baracat EC
Gynecol Endocrinol; 2019 Feb; 35(2):133-137. PubMed ID: 30614308
[TBL] [Abstract][Full Text] [Related]
16. Proinflammatory environment and role of TNF-α in endometrial function of obese women having polycystic ovarian syndrome.
Oróstica L; Astorga I; Plaza-Parrochia F; Vera C; García V; Carvajal R; Gabler F; Romero C; Vega M
Int J Obes (Lond); 2016 Nov; 40(11):1715-1722. PubMed ID: 27569685
[TBL] [Abstract][Full Text] [Related]
17. Endometrial expression of Cyr61: a marker of estrogenic activity in normal and abnormal endometrium.
MacLaughlan SD; Palomino WA; Mo B; Lewis TD; Lininger RA; Lessey BA
Obstet Gynecol; 2007 Jul; 110(1):146-54. PubMed ID: 17601910
[TBL] [Abstract][Full Text] [Related]
18. Endometrial gene expression in the window of implantation is altered in obese women especially in association with polycystic ovary syndrome.
Bellver J; Martínez-Conejero JA; Labarta E; Alamá P; Melo MA; Remohí J; Pellicer A; Horcajadas JA
Fertil Steril; 2011 Jun; 95(7):2335-41, 2341.e1-8. PubMed ID: 21481376
[TBL] [Abstract][Full Text] [Related]
19. Expression of GPR30, ERα and ERβ in endometrium during window of implantation in patients with polycystic ovary syndrome: a pilot study.
Wang A; Ji L; Shang W; Li M; Chen L; White RE; Han G
Gynecol Endocrinol; 2011 Apr; 27(4):251-5. PubMed ID: 21269226
[TBL] [Abstract][Full Text] [Related]
20. Obesity reduces the expression of GLUT4 in the endometrium of normoinsulinemic women affected by the polycystic ovary syndrome.
Mozzanega B; Mioni R; Granzotto M; Chiarelli S; Xamin N; Zuliani L; Sicolo N; Marchesoni D; Vettor R
Ann N Y Acad Sci; 2004 Dec; 1034():364-74. PubMed ID: 15731326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
